|
|
 | | | |
- close
- close
- close
- close
Minerals Technologies (MTX) |
Benzinga
May 10
Comment
Below are the top small-cap synthetics stocks on NYSE and the NASDAQ in terms of revenue.
The trailing-twelve-month revenue at Minerals Technologies (NYSE: MTX) is $999.77 million. Minerals Technologies' operating margin for the same period is...
StreetInsider.com
Apr 26
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Minerals+Technologies+Inc.+%28MTX%29+Tops+Q1+EPS+by+2c/8281258.html for the full story.
Benzinga
Feb 27
Comment
Antares Pharma, Inc. (NASDAQ: ATRS) today announced that the New Drug
Application (NDA) for OTREXUP™, a potential new product for the subcutaneous
delivery of methotrexate (MTX) using Medi-Jet™ technology, has been accepted
by the U.S. Food...
Benzinga
Feb 6
Comment
JP Morgan downgraded Minerals Technologies (NYSE: MTX) from Overweight to Neutral and raised the price target from $39.00 to $43.00.
JP Morgan noted, "We believe MTX's unleveraged balance sheet, its diligence in reducing costs and...
StreetInsider.com
Jan 31
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Minerals+Technologies+Inc.+%28MTX%29+Tops+Q4+EPS+by+3c/8049381.html for the full story.
Benzinga
Dec 12
Comment
Minerals Technologies Inc. (NYSE: MTX) announced today
it has signed an agreement with Henan Jianghe Paper Co., Ltd. for the
construction of a 22,000-metric ton satellite precipitated calcium carbonate
(PCC) plant at Jianghe Paper's papermaking...
Benzinga
Dec 12
Comment
SinoCoking Coal and Coke Chemical Industries (NASDAQ: SCOK) shares lost 5.50% to create a new 52-week low of $1.20. SinoCoking Coal and Coke Chemical Industries' trailing-twelve-month ROE is 3.76%.
Minerals Technologies (NYSE: MTX) shares fell...
Benzinga
Nov 14
Comment
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga
Nov 14
Comment
In a report published Tuesday, BMO Capital Markets reiterated Celgene Corporation (NASDAQ: CELG) following PALACE-1 Study Results that came out better than expected and maintained its price target of $90.
BMO Capital Markets noted, "PALACE-1...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
